In this episode, we are privileged to feature Peter Vranes, the co-founder of Nutromics, an Australian MedTech company revolutionizing healthcare through continuous real-time molecular monitoring. Peter shares how his company's smart patch biosensor can measure molecular targets continuously and in real-time. He explains how molecular targeting is done and how it can improve patient outcomes. He talks of the core application of the platform and how it can change the trajectory of the Medtech industry. This innovative technology can impact and save thousands of lives, so it's exciting to hear Peter discuss it. Learn more about this smart patch biosensor in our interview, so please tune in and enjoy!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket